JP2014515356A5 - - Google Patents

Download PDF

Info

Publication number
JP2014515356A5
JP2014515356A5 JP2014511611A JP2014511611A JP2014515356A5 JP 2014515356 A5 JP2014515356 A5 JP 2014515356A5 JP 2014511611 A JP2014511611 A JP 2014511611A JP 2014511611 A JP2014511611 A JP 2014511611A JP 2014515356 A5 JP2014515356 A5 JP 2014515356A5
Authority
JP
Japan
Prior art keywords
composition
dry powder
value
vancomycin
max
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014511611A
Other languages
English (en)
Japanese (ja)
Other versions
JP6012716B2 (ja
JP2014515356A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/038775 external-priority patent/WO2012159103A1/en
Publication of JP2014515356A publication Critical patent/JP2014515356A/ja
Publication of JP2014515356A5 publication Critical patent/JP2014515356A5/ja
Application granted granted Critical
Publication of JP6012716B2 publication Critical patent/JP6012716B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014511611A 2011-05-19 2012-05-21 乾燥粉末バンコマイシン組成物および関連する方法 Expired - Fee Related JP6012716B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161487971P 2011-05-19 2011-05-19
US61/487,971 2011-05-19
PCT/US2012/038775 WO2012159103A1 (en) 2011-05-19 2012-05-21 Dry powder vancomycin compositions and associated methods

Publications (3)

Publication Number Publication Date
JP2014515356A JP2014515356A (ja) 2014-06-30
JP2014515356A5 true JP2014515356A5 (es) 2015-06-18
JP6012716B2 JP6012716B2 (ja) 2016-10-25

Family

ID=47177374

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014511611A Expired - Fee Related JP6012716B2 (ja) 2011-05-19 2012-05-21 乾燥粉末バンコマイシン組成物および関連する方法

Country Status (11)

Country Link
EP (1) EP2709646A4 (es)
JP (1) JP6012716B2 (es)
KR (1) KR101763195B1 (es)
CN (1) CN103717231B (es)
AU (1) AU2012254999B2 (es)
BR (1) BR112013029803B1 (es)
CA (2) CA2981038C (es)
IL (1) IL229506B (es)
MX (1) MX346244B (es)
SG (1) SG195038A1 (es)
WO (1) WO2012159103A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2594368T3 (es) 2005-12-08 2016-12-19 Insmed Incorporated Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
CN104884047A (zh) * 2012-11-29 2015-09-02 英斯梅德股份有限公司 稳定的万古霉素制剂
EP3007689B1 (en) 2013-01-10 2018-03-07 Pulmokine, Inc. Non-selective kinase inhibitors
CN104043104B (zh) * 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
JP6483714B2 (ja) * 2013-10-11 2019-03-13 ローレンス エス. ジスマン, 噴霧乾燥製剤
CA2940560A1 (en) * 2014-02-28 2015-09-03 Algipharma As Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function
JP6552528B2 (ja) * 2014-03-14 2019-07-31 キューティスファーマ インコーポレーテッドCutispharma, Inc. バンコマイシン経口液体のための組成物および方法
CA2949078C (en) 2014-05-15 2022-09-20 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
JP6797795B2 (ja) * 2014-11-06 2020-12-09 クセリア ファーマシューティカルズ エーピーエスXellia Pharmaceuticals ApS グリコペプチド組成物
CN107106585B (zh) * 2015-02-06 2021-01-01 杭州美南医药科技有限公司 万古霉素的水溶液制剂
GB201609940D0 (en) * 2016-06-07 2016-07-20 Novabiotics Ltd Microparticles
WO2018081567A1 (en) 2016-10-27 2018-05-03 Pulmokine, Inc. Combination therapy for treating pulmonary hypertension
CN106963939A (zh) * 2017-03-22 2017-07-21 永信药品工业(昆山)股份有限公司 盐酸万古霉素药物组合物及其制备方法
WO2018217800A1 (en) * 2017-05-22 2018-11-29 Insmed Incorporated Glycopeptide derivative compounds and uses thereof
EP3773505A4 (en) 2018-03-30 2021-12-22 Insmed Incorporated PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
WO2020081599A1 (en) * 2018-10-15 2020-04-23 Savara Inc. Separation of vancomycin and its degradation products

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
FI79651C (fi) 1982-10-08 1990-02-12 Glaxo Group Ltd Doseringsanordning foer medicin.
GR861995B (en) 1985-07-30 1986-11-04 Glaxo Group Ltd Devices for administering medicaments to patients
JPH03193735A (ja) * 1989-12-22 1991-08-23 Shionogi & Co Ltd グリコペプチド系抗生物質の安定化組成物
JPH05963A (ja) 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6051256A (en) * 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
JP4142149B2 (ja) * 1997-07-10 2008-08-27 明治製菓株式会社 バンコマイシンの凍結乾燥製剤
US6586008B1 (en) * 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
HU229310B1 (en) * 1999-10-29 2013-10-28 Nektar Therapeutics Dry powder compositions having improved dispersivity
CA2464656C (en) * 2001-11-01 2013-07-16 Nektar Therapeutics Spray drying methods and compositions thereof
DE10358387A1 (de) * 2003-12-13 2005-07-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung
FR2872044B1 (fr) * 2004-06-28 2007-06-29 Flamel Technologies Sa Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire
EP2050437A1 (en) * 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
HUE038428T2 (hu) * 2008-10-07 2018-10-29 Horizon Orphan Llc Aeroszol fluorokinolon készítmények javított farmakokinetika érdekében
MX354829B (es) * 2009-03-26 2018-03-22 Pulmatrix Operating Co Inc Formulaciones de polvo seco y metodos para el tratamiento de enfermedades pulmonares.
US20120058198A1 (en) * 2009-03-26 2012-03-08 Pulmatrix, Inc. Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis

Similar Documents

Publication Publication Date Title
JP2014515356A5 (es)
ES2823000T3 (es) Formulaciones muco-adhesivas de liberación controlada de levodopa y/o ésteres de levodopa y usos de las mismas
JP2015509788A5 (es)
CA2836643C (en) Dry powder vancomycin compositions and associated methods
JP2014501224A5 (es)
JP2011116788A5 (es)
AU2007267159B2 (en) Lipoic acid pellets
JP2016523250A5 (es)
JP2016534142A5 (es)
JP2010537989A5 (es)
JP2009530415A5 (es)
JP2011502997A5 (es)
JP2016500088A5 (es)
AU2012254999A1 (en) Dry powder vancomycin compositions and associated methods
JP2015007131A5 (es)
RU2018144108A (ru) Никотиносодержащие частицы
EA031255B1 (ru) Состав с отсроченным высвобождением, содержащий гранулы цистеамина, и способы его получения и применения
WO2018072709A1 (zh) 医药微丸的干粉包衣组合物
JP2013508289A5 (es)
JP2013505233A5 (es)
JP2013523676A5 (es)
JP2012509922A5 (es)
JP2011251959A5 (es)
JPWO2019237028A5 (ja) 吸入のための組成物
RU2014115289A (ru) Композиция пазопаниба